title: What can we expect from long-acting formulations for schizophrenia?
authors.affiliation: Division of Translational Neuroscience, Department of Psychiatry, University of Pennsylvania, Translational Research Laboratories, Philadelphia, PA 19104, USA. siegels@mail.med.upenn.edu
authors.forename: Steven J
authors.initials: SJ
authors.lastname: Siegel